MedTrace Logo

SpO2 Validation Study-Philips Optimus

NCT07215429 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2026-04-13

No results posted yet for this study

Summary

Validation study to validate the SpO2 accuracy performance of the Sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry

Conditions

  • Pulse Oximetry, Oxygen Measurements, SpO2

Interventions

DEVICE

No intervention

No intervention

Sponsors & Collaborators

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Monica Rabanal, NP · Element Desaturation Labratory

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-09
Primary Completion
2025-09-19
Completion
2025-09-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07215429 on ClinicalTrials.gov